IAIoannis Alexopoulos

Ioannis Alexopoulos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ioannis Alexopoulos has a total of 206 co-authors. Here are the top co-authors by number of shared publications:

  • Susanne Herold

    Department of Medicine V, Internal Medicine, Infectious Diseases and Infection Control, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), German Center for Infection Research (DZIF), Justus-Liebig-University Giessen (JLU), Giessen, Germany

    9 shared publications
  • Ana Ivonne Vazquez-Armendariz

    University of Bonn, Transdisciplinary Research Area Life and Health, Organoid Biology, Life & Medical Sciences Institute, Bonn, Germany

    5 shared publications
  • Mikael Simons

    Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany

    5 shared publications
  • Werner Seeger

    Department of Internal Medicine, Universities of Giessen and Marburg Lung Center (UGMLC) Member of the German Center for Lung Research (DZL) Giessen Germany

    5 shared publications
  • Jochen Wilhelm

    Institute for Lung Health (ILH), Universities Giessen & Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Justus-Liebig-University Giessen, Giessen, Germany

    4 shared publications
  • Ali Khadim

    Excellence Cluster Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig-University Giessen, German Center for Lung Research (DZL), Giessen, Germany

    3 shared publications

Latest Publications

  • Open Access

    TNF superfamily member 14 drives post-influenza depletion of alveolar macrophages, enabling secondary pneumococcal pneumonia

    by Christina Malainou, Christin Peteranderl, Maximiliano Ruben Ferrero, Ana Ivonne Vazquez-Armendariz, Ioannis Alexopoulos, Katharina Franz, Klara Knippenberg, Julian Better, Mohammad Estiri, Cheng-Yu Wu, et al.

    Secondary bacterial infection, often caused by Streptococcus pneumoniae , is one of the most frequent and severe complications of influenza A virus–induced (IAV-induced) pneumonia. Phenotyping of the pulmonary immune cell landscape after IAV infection revealed a substantial depletion of the tissue-resident alveolar macrophage (TR-AM) population at day 7, which was associated with increased susceptibility to S. pneumoniae outgrowth. To elucidate the molecular mechanisms underlying TR-AM depletion, and to define putative targets for treatment, we combined single-cell transcriptomics and cell-specific PCR profiling in an unbiased manner, using in vivo models of IAV infection and IAV and S. pneumoniae coinfection. The TNF superfamily 14 (TNFSF14) ligand/receptor axis was revealed as the driving force behind post-influenza TR-AM death during the early infection phase, enabling the transition to pneumococcal pneumonia, whereas intrapulmonary transfer of genetically modified TR-AMs and antibody-mediated neutralization of specific pathway components alleviated disease severity. With mainly neutrophilic expression and high abundance in the bronchoalveolar fluid of patients with severe virus-induced acute respiratory distress syndrome, TNFSF14 emerged as a key determinant of virus-driven lung injury. Targeting the TNFSF14-mediated intercellular communication network in the virus-infected lung can, therefore, improve host defense, minimizing the risk of subsequent bacterial pneumonia and ameliorating the disease outcome.


  • Cell type–specific efferocytosis determines functional plasticity of alveolar macrophages

    by Julian Better, Mohammad Estiri, Michael Wetstein, Learta Pervizaj-Oruqaj, Christina Malainou, Victoria Ogungbemi-Alt, Maximiliano Ruben Ferrero, Martin Langelage, Irina Kuznetsova, Ana Ivonne Vazquez-Armendariz, et al.

    Resolution of lung injuries is vital to maintain gas exchange, but there is an increased risk of secondary bacterial infections during this stage. Alveolar macrophages (AMs) are crucial to clear bacteria and control the resolution of inflammation, but environmental cues that switch functional phenotypes of AMs remain incompletely understood. Here, we found that AMs lack the capacity to mount an effective immune response against bacteria during resolution of inflammation. Neutrophil (PMN)–derived myeloperoxidase (MPO) fueled canonical glutaminolysis via the mitochondrial membrane transporter uncoupling protein–2 (UCP2), resulting in decreased mtROS-dependent killing of bacteria and secretion of pro-inflammatory cytokines. MPO-enhanced UCP2 expression inhibited mitochondrial hyperpolarization and boosted efferocytosis irrespective of the presence of bacterial pathogens. Conversely, efferocytosis of other cell types resulted in a distinct anti-inflammatory AM phenotype while maintaining antibacterial phenotypic plasticity. Overall, our findings indicate that the uptake of apoptotic PMNs or MPO switches AMs to prioritize resolution of inflammation over antibacterial responses, a feature that is conserved in murine extrapulmonary macrophages and human AMs.


  • Open Access

    Monitoring the point spread function for quality control of Fluorescent microscopes v2 v2

    by Glyn Nelson, Ioannis Alexopoulos, Luis-Francisco Acevedo-Hueso, Maria Azevedo, Fabio Barachati, Yury Belyaev, Mariana T Carvalho, Yann Cesbron, Aurelien Dauphin, Alexander D Corbett, et al.

    This protocol focuses on measuring the microscope's lateral and axial resolution, essential for reporting size measurements of near-resolution limit objects or distances between them. Here resolution is expressed as the Full Width at Half Maximum (FWHM) of a measured Point Spread Function (PSF) of sub-resolution size beads. PSF is highly related to objective quality and condition, but also depends strongly upon other parameters ranging from sample preparation to signal detection. Monitoring PSF over time will identify possible aberrations in the system (e.g., damaged, unclean objective, defective or not adapted oil, etc.). We define test sample preparation, image acquisition, and data analysis protocols for point scanning and spinning disk confocal microscopes as well as widefield fluorescent microscopes.

  • Microscopic computed tomography with AI-CNN-powered image analysis: the path to phenotype bleomycin-induced lung injury

    by Ingrid Henneke, Christina Pilz, Jochen Wilhelm, Ioannis Alexopoulos, Aysan Ezaddoustdar, Regina Mukhametshina, Norbert Weissmann, Hossein Ardeschir Ghofrani, Friedrich Grimminger, Werner Seeger, et al.

    Microscopic computed tomography (µCT) imaging combined with an artificial intelligence (AI)-convolutional neural network (CNN)-powered lung segmentation is a rapid and powerful tool for noninvasive phenotyping of bleomycin mice over the course of the disease. This, in turn, allows earlier and more reliable identification of therapeutic effects of new drug candidates, ultimately leading to the reduction of unnecessary procedures in animals in pharmacological research.


  • Open Access

    An Optimized Protocol for the Generation of Alveolospheres from Wild-Type Mice

    by Mahsa Zabihi, Ali Khadim, Theresa M. Schäfer, Ioannis Alexopoulos, Marek Bartkuhn, Elie El Agha, Ana I. Vazquez-Armendariz, Susanne Herold

    Organoid models have become an integral part of the research methodology in the lung field. These systems allow for the study of progenitor and stem cell self-renewal, self-organization, and differentiation. Distinct models of lung organoids mimicking various anatomical regions of mature lungs have emerged in parallel to the increased gain of knowledge regarding epithelial stem and progenitor cell populations and the corresponding mesenchymal cells that populate the in vivo niche. In the distal lung, type 2 alveolar epithelial cells (AEC2s) represent a stem cell population that is engaged in regenerative mechanisms in response to various insults. These cells self-renew and give rise to AEC1s that carry out gas exchange. Multiple experimental protocols allowing the generation of alveolar organoids, or alveolospheres, from murine lungs have been described. Among the drawbacks have been the requirement of transgenic mice allowing the isolation of AEC2s with high viability and purity, and the occasional emergence of bronchiolar and bronchioalveolar organoids. Here, we provide a refined gating strategy and an optimized protocol for the generation of alveolospheres from wild-type mice. Our approach not only overcomes the need for transgenic mice to generate such organoids, but also yields a pure culture of alveolospheres that is devoid of bronchiolar and bronchioalveolar organoids. Our protocol contributes to the standardization of this important research tool.


  • GLI1+ Cells Contribute to Vascular Remodeling in Pulmonary Hypertension

    by Xuran Chu, Vahid Kheirollahi, Arun Lingampally, Prakash Chelladurai, Chanil Valasarajan, Ana Ivonne Vazquez-Armendariz, Stefan Hadzic, Ali Khadim, Oleg Pak, Stefano Rivetti, et al.

    BACKGROUND: The precise origin of newly formed ACTA2+ (alpha smooth muscle actin-positive) cells appearing in nonmuscularized vessels in the context of pulmonary hypertension is still debatable although it is believed that they predominantly derive from preexisting vascular smooth muscle cells (VSMCs). METHODS: Gli1 Cre-ERT2 ; tdTomato flox mice were used to lineage trace GLI1+ (glioma-associated oncogene homolog 1-positive) cells in the context of pulmonary hypertension using 2 independent models of vascular remodeling and reverse remodeling: hypoxia and cigarette smoke exposure. Hemodynamic measurements, right ventricular hypertrophy assessment, flow cytometry, and histological analysis of thick lung sections followed by state-of-the-art 3-dimensional reconstruction and quantification using Imaris software were used to investigate the contribution of GLI1+ cells to neomuscularization of the pulmonary vasculature. RESULTS: The data show that GLI1+ cells are abundant around distal, nonmuscularized vessels during steady state, and this lineage contributes to around 50% of newly formed ACTA2+ cells around these normally nonmuscularized vessels. During reverse remodeling, cells derived from the GLI1+ lineage are largely cleared in parallel to the reversal of muscularization. Partial ablation of GLI1+ cells greatly prevented vascular remodeling in response to hypoxia and attenuated the increase in right ventricular systolic pressure and right heart hypertrophy. Single-cell RNA sequencing on sorted lineage-labeled GLI1+ cells revealed an Acta2 high fraction of cells with pathways in cancer and MAPK (mitogen-activated protein kinase) signaling as potential players in reprogramming these cells during vascular remodeling. Analysis of human lung-derived material suggests that GLI1 signaling is overactivated in both group 1 and group 3 pulmonary hypertension and can promote proliferation and myogenic differentiation. CONCLUSIONS: Our data highlight GLI1+ cells as an alternative cellular source of VSMCs in pulmonary hypertension and suggest that these cells and the associated signaling pathways represent an important therapeutic target for further studies.


  • Top Cited Papers
    Open Access

    Alveolar macrophage-expressed Plet1 is a driver of lung epithelial repair after viral pneumonia

    by Learta Pervizaj-Oruqaj, Balachandar Selvakumar, Maximiliano Ruben Ferrero, Monika Heiner, Christina Malainou, Rolf David Glaser, Jochen Wilhelm, Marek Bartkuhn, Astrid Weiss, Ioannis Alexopoulos, et al.

    Influenza A virus (IAV) infection mobilizes bone marrow-derived macrophages (BMDM) that gradually undergo transition to tissue-resident alveolar macrophages (TR-AM) in the inflamed lung. Combining high-dimensional single-cell transcriptomics with complex lung organoid modeling, in vivo adoptive cell transfer, and BMDM-specific gene targeting, we found that transitioning (“regenerative”) BMDM and TR-AM highly express Placenta-expressed transcript 1 (Plet1). We reveal that Plet1 is released from alveolar macrophages, and acts as important mediator of macrophage-epithelial cross-talk during lung repair by inducing proliferation of alveolar epithelial cells and re-sealing of the epithelial barrier. Intratracheal administration of recombinant Plet1 early in the disease course attenuated viral lung injury and rescued mice from otherwise fatal disease, highlighting its therapeutic potential.


  • Open Access

    Pulmonary siRNA Delivery with Sophisticated Amphiphilic Poly(Spermine Acrylamides) for the Treatment of Lung Fibrosis

    by Friederike Adams, Christoph M. Zimmermann, Domizia Baldassi, Thomas M. Pehl, Philipp Weingarten, Iris Kachel, Moritz Kränzlein, David C. Jürgens, Peter Braubach, Ioannis Alexopoulos, et al.

    RNA interference (RNAi) is an efficient strategy to post‐transcriptionally silence gene expression. While all siRNA drugs on the market target the liver, the lung offers a variety of currently undruggable targets, which can potentially be treated with RNA therapeutics. To achieve this goal, the synthesis of poly(spermine acrylamides) (P(SpAA) is reported herein. Polymers are prepared via polymerization of N‐acryloxysuccinimide (NAS) and afterward this active ester is converted into spermine‐based pendant groups. Copolymerizations with decylacrylamide are employed to increase the hydrophobicity of the polymers. After deprotection, polymers show excellent siRNA encapsulation to obtain perfectly sized polyplexes at very low polymer/RNA ratios. In vitro 2D and 3D cell culture, ex vivo and in vivo experiments reveal superior properties of amphiphilic spermine‐copolymers with respect to delivery of siRNA to lung cells in comparison to commonly used lipid‐based transfection agents. In line with the in vitro results, siRNA delivery to human lung explants confirm more efficient gene silencing of protease‐activated receptor 2 (PAR2), a G protein‐coupled receptor involved in fibrosis. This study reveals the importance of the balance between efficient polyplex formation, cellular uptake, gene knockdown, and toxicity for efficient siRNA delivery in vitro, in vivo, and in fibrotic human lung tissue ex vivo.


  • Impact of GM-CSF on lung epithelial cell injury and repair in severe influenza virus pneumonia

    by T Schäfer, A I Vazquez-Armendariz, L Sperling, M Heiner, I Alexopoulos, J P Mengel, T Hain, W Seeger, S Herold

    GM-CSF (granulocyte-macrophage colony-stimulating factor) is a myeloid growth factor that has been implicated in alveolar epithelial type 2 cell (AECII) repair after lung damage. However, the distinct GM-CSF-mediated signaling pathways driving epithelial (stem) cell repair during viral infections remain elusive. Therefore, this study aimed to identify the molecular mechanisms involved in the epithelial regenerative effects of GM-CSF following influenza A virus (IAV)-induced injury. During IAV infection, GM-CSF is expressed by BASC and AECII which significantly induces their proliferation. In our in vitro bronchioalveolar lung organoid (BALO) model the GM-CSF/GM-CSF receptor axis was necessary for proper alveolarization. Bulk RNA sequencing revealed an upregulation of catabolic pathways in BASC of infected csf2-/- compared to infected WT mice. The treatment of infected AEC from csf2-/- mice with recombinant GM-CSF caused downregulation of AMPK, a master regulator of metabolic pathways, and activation of mTORC1. Accordingly, cell cycle genes, Ccnd1 and cMyc, were upregulated in infected WT but not in csf2-/- AECII. Treatment of lung organoids with AMPK inhibitor or mTORC1 activator supported organoid forming efficiency and alveolarization. Lastly, IAV-infected csf2-/- mice treated with AMPK inhibitor, Compound C, displayed an increase in BASC and AECII proliferation and promoted epithelial barrier repair. In summary, these data indicate that the protective effects of GM-CSF in BASC and AECII after viral lung injury are mediated by downregulation of AMPK signaling inducing mTORC1 activation, therefore, supporting epithelial stem cells9 proliferation and restoration of the alveolar barrier.